{"id":65523,"date":"2023-12-20T09:41:58","date_gmt":"2023-12-20T08:41:58","guid":{"rendered":"https:\/\/www.embl.org\/news\/?p=65523"},"modified":"2024-03-22T11:21:46","modified_gmt":"2024-03-22T10:21:46","slug":"unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/","title":{"rendered":"Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0"},"content":{"rendered":"\n<p>Neuroendocrine tumours (NETs) are relatively rare tumours showing an increasing incidence and with an uncertain prognosis. While some are slow-growing, others are aggressive and challenging to treat. Unfortunately, predicting which tumours will become aggressive remains a challenge, emphasising the need for more research on the topic. However, the limited number of pre-clinical models for NETs has hindered research efforts, as these tumours are difficult to grow in culture.<\/p>\n\n\n\n<p>Researchers from the Organoid Group at the Hubrecht Institute and the Rare Cancers Genomics Team at IARC\/WHO have developed a method to grow neuroendocrine tumours (NETs) of the lung in the lab \u2013 a study that has been recently published in the journal <em>Cancer Cell<\/em>, a forum to promote major advances in cancer research and oncology.&nbsp; Talya Dayton, a group leader at EMBL Barcelona who aims to understand how cells behave in health and disease, co-led this study during her postdoc at the Hubrecht Institute.<\/p>\n\n\n\n<p>During her postdoc, Dayton successfully grew patient-derived tumour organoids from low-grade pulmonary NETs for the first time. These organoids serve as a crucial resource for the field. Using them, the researchers found that some pulmonary NETs rely on a protein called epidermal growth factor (EGF) to grow. Therefore, inhibiting the EGF receptor could be a potential treatment approach for these tumours.&nbsp;<\/p>\n\n\n\n<p>The surprising discovery that NETs are dependent on growth factors challenges the conventional belief that tumours are growth-factor independent. This dependence may explain why some tumours grow slowly, and it suggests that one of the ways NETs can become aggressive is by becoming growth-factor independent.<\/p>\n\n\n\n<p>While further research is needed to confirm these findings, they raise the possibility that patients with pulmonary NETs expressing EGFR could benefit from treatment with EGFR inhibitors. Given the common use of EGFR inhibitors for other tumours, this could significantly impact patients with pulmonary NETs.<\/p>\n\n\n\n<p>&#8220;This work lays the foundation for the work <a href=\"https:\/\/www.embl.org\/groups\/dayton\/\">my group<\/a> is doing at EMBL Barcelona,\u201d said Dayton. \u201cWe are using the patient-derived tumour organoid models I generated and described in this paper to better understand how NETs progress and become aggressive.&#8221;&nbsp;<\/p>\n\n\n\n<p>Additionally, the team is now using tumour organoid models of aggressive neuroendocrine carcinomas to identify new therapeutic vulnerabilities in these cancers. They also plan to use this system to try and predict therapeutic strategies that can either prevent the malignant transition to aggressive disease, or reverse it.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study the disease in the lab.<\/p>\n","protected":false},"author":157,"featured_media":65531,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2,17591],"tags":[38,13966,2010,13968,539,653],"embl_taxonomy":[9762],"class_list":["post-65523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science","category-science-technology","tag-cancer","tag-dayton","tag-growth-factor","tag-organoids","tag-research-highlight","tag-tumour","embl_taxonomy-embl-barcelona"],"acf":{"featured":true,"show_featured_image":false,"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"article_intro":"<p>A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study them in the lab<\/p>\n","related_links":[{"link_description":"The Hubrecht Institute ","link_url":"https:\/\/www.hubrecht.eu"},{"link_description":"Dayton Group","link_url":"https:\/\/www.embl.org\/groups\/dayton\/"}],"source_article":[{"publication_title":"Druggable Growth Dependencies and Tumor Evolution Analysis in Patient-Derived Organoids of Neuroendocrine Neoplasms from Multiple Body Sites ","publication_link":{"title":"","url":"https:\/\/www.cell.com\/cancer-cell\/pdf\/S1535-6108(23)00398-7.pdf","target":""},"publication_authors":"Dayton T., et al.","publication_source":"Cancer cell","publication_date":"11 December 2023","publication_doi":"10.1016\/j.ccell.2023.11.007."}],"in_this_article":false,"press_contact":"None","article_translations":false,"languages":""},"embl_taxonomy_terms":[{"uuid":"a:3:{i:0;s:36:\"b14d3f13-5670-44fb-8970-e54dfd9c921a\";i:1;s:36:\"89e00fee-87f4-482e-a801-4c3548bb6a58\";i:2;s:36:\"762176bb-d12e-4c94-8964-6dbb76e15c42\";}","parents":[],"name":["EMBL Barcelona"],"slug":"embl-barcelona","description":"Where &gt; All EMBL sites &gt; EMBL Barcelona"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0 | EMBL<\/title>\n<meta name=\"description\" content=\"A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study the disease in the lab.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0 | EMBL\" \/>\n<meta property=\"og:description\" content=\"A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study the disease in the lab.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-20T08:41:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-22T10:21:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berenice Bernal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berenice Bernal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/\"},\"author\":{\"name\":\"Berenice Bernal\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/d61ec67eb284792709cb1daaf50186a3\"},\"headline\":\"Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0\",\"datePublished\":\"2023-12-20T08:41:58+00:00\",\"dateModified\":\"2024-03-22T10:21:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/\"},\"wordCount\":402,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg\",\"keywords\":[\"cancer\",\"Dayton\",\"growth factor\",\"organoids\",\"research highlight\",\"tumour\"],\"articleSection\":[\"Science\",\"Science &amp; Technology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/\",\"url\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/\",\"name\":\"Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0 | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg\",\"datePublished\":\"2023-12-20T08:41:58+00:00\",\"dateModified\":\"2024-03-22T10:21:46+00:00\",\"description\":\"A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study the disease in the lab.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg\",\"width\":1000,\"height\":600,\"caption\":\"A culture of patient-derived neuroendocrine tumour organoids. Credit: Talya Dayton\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/d61ec67eb284792709cb1daaf50186a3\",\"name\":\"Berenice Bernal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2a443948b6040122f69efe7502c96b79e1802f1bd90ce5e626fb1e9901775e86?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2a443948b6040122f69efe7502c96b79e1802f1bd90ce5e626fb1e9901775e86?s=96&d=mm&r=g\",\"caption\":\"Berenice Bernal\"},\"url\":\"https:\/\/www.embl.org\/news\/author\/berenice-bernal-riveraembl-de\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0 | EMBL","description":"A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study the disease in the lab.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/","og_locale":"en_US","og_type":"article","og_title":"Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0 | EMBL","og_description":"A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study the disease in the lab.","og_url":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2023-12-20T08:41:58+00:00","article_modified_time":"2024-03-22T10:21:46+00:00","og_image":[{"width":1000,"height":600,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg","type":"image\/jpeg"}],"author":"Berenice Bernal","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Berenice Bernal","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/"},"author":{"name":"Berenice Bernal","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/d61ec67eb284792709cb1daaf50186a3"},"headline":"Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0","datePublished":"2023-12-20T08:41:58+00:00","dateModified":"2024-03-22T10:21:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/"},"wordCount":402,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg","keywords":["cancer","Dayton","growth factor","organoids","research highlight","tumour"],"articleSection":["Science","Science &amp; Technology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/","url":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/","name":"Unveiling the vulnerabilities of pulmonary neuroendocrine tumours\u00a0 | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg","datePublished":"2023-12-20T08:41:58+00:00","dateModified":"2024-03-22T10:21:46+00:00","description":"A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study the disease in the lab.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/science\/unveiling-the-vulnerabilities-of-pulmonary-neuroendocrine-tumours\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg","width":1000,"height":600,"caption":"A culture of patient-derived neuroendocrine tumour organoids. Credit: Talya Dayton"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/d61ec67eb284792709cb1daaf50186a3","name":"Berenice Bernal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2a443948b6040122f69efe7502c96b79e1802f1bd90ce5e626fb1e9901775e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a443948b6040122f69efe7502c96b79e1802f1bd90ce5e626fb1e9901775e86?s=96&d=mm&r=g","caption":"Berenice Bernal"},"url":"https:\/\/www.embl.org\/news\/author\/berenice-bernal-riveraembl-de\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/12\/tomour-organoids_1000600.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/65523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/157"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=65523"}],"version-history":[{"count":14,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/65523\/revisions"}],"predecessor-version":[{"id":65559,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/65523\/revisions\/65559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/65531"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=65523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=65523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=65523"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=65523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}